Paracrine/autocrine activation of NGF signaling has been implicated in tumor progression, cell survival and metastasis and deletion or mutation of Cav-1 have been reported for certain cancers, notably breast cancer [63,64,65,66,67] while overexpression has been observed in certain prostate cancer lines [26,68]. This evidence concerns the gene NGF and breast carcinoma.